How Do Presenting Symptoms and Outcomes Differ by Race/Ethnicity Among Hospitalized Patients With Coronavirus Disease 2019 Infection? Experience in Massachusetts
- 22 August 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 73 (11) , e4131-e4138
Abstract
Background: Population-based literature suggests severe acute respiratory syndrome coronavirus 2 infection may disproportionately affect racial/ethnic minorities; however, patient-level observations of hospitalization outcomes by race/ethnicity are limited. Our aim in this study was to characterize coronavirus disease 2019 (COVID-19)–associated morbidity and in-hospital mortality by race/ethnicity. Methods: This was a retrospective analysis of 9 Massachusetts hospitals including all consecutive adult patients hospitalized with laboratory-confirmed COVID-19. Measured outcomes were assessed and compared by patient-reported race/ethnicity, classified as white, black, Latinx, Asian, or other. Student t test, Fischer exact test, and multivariable regression analyses were performed. Results: A total of 379 patients (aged 62.9 ± 16.5 years; 55.7% men) with confirmed COVID-19 were included (49.9% white, 13.7% black, 29.8% Latinx, 3.7% Asian), of which 376 (99.2%) were insured (34.3% private, 41.2% public, 23.8% public with supplement). Latinx patients were younger, had fewer cardiopulmonary disorders, were more likely to be obese, more frequently reported fever and myalgia, and had lower D-dimer levels compared with white patients (P < .05). On multivariable analysis controlling for age, gender, obesity, cardiopulmonary comorbidities, hypertension, and diabetes, no significant differences in in-hospital mortality, intensive care unit admission, or mechanical ventilation by race/ethnicity were found. Diabetes was a significant predictor for mechanical ventilation (odds ratio [OR], 1.89; 95% confidence interval [CI], 1.11–3.23), while older age was a predictor of in-hospital mortality (OR, 4.18; 95% CI, 1.94–9.04). Conclusions: In this multicenter cohort of hospitalized COVID-19 patients in the largest health system in Massachusetts, there was no association between race/ethnicity and clinically relevant hospitalization outcomes, including in-hospital mortality, after controlling for key demographic/clinical characteristics. These findings serve to refute suggestions that certain races/ethnicities may be biologically predisposed to poorer COVID-19 outcomes.Keywords
Funding Information
- National Institutes of Health (T32 DK007533–35)
- Health Services Research
- Defense Health Agency
- Vattikuti Urology Institute
This publication has 14 references indexed in Scilit:
- COVID-19 and African AmericansJAMA, 2020
- Obesity and impaired metabolic health in patients with COVID-19Nature Reviews Endocrinology, 2020
- Health Inequalities and Infectious Disease Epidemics: A Challenge for Global Health SecurityBiosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science, 2014
- Massachusetts Health Care Reform and Reduced Racial Disparities in Minimally Invasive SurgeryJAMA Surgery, 2013
- The impact of health care reform on hospital and preventive care: Evidence from MassachusettsJournal of Public Economics, 2012
- Race‐specific WBC and neutrophil count reference intervalsInternational Journal of Laboratory Hematology, 2010
- Protection of Racial/Ethnic Minority Populations During an Influenza PandemicAmerican Journal of Public Health, 2009
- Pandemic Influenza Planning in the United States from a Health Disparities PerspectiveEmerging Infectious Diseases, 2008
- Preparing Racially And Ethnically Diverse Communities For Public Health EmergenciesHealth Affairs, 2007
- Race, Ethnicity and Disasters in the United States: A Review of the LiteratureDisasters, 1999